KRP 197

Known as: KRP-197 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2011
0119982011

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Imidafenacin (KRP-197) is a novel antimuscarinic agent for overactive bladder treatment. The inhibitory effect of imidafenacin on… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
2007
2007
Imidafenacin (CAS 170105-16-5, KRP-197, ONO-8025) is an antagonist for the muscarinic acetylcholine (ACh) receptor currently… (More)
Is this relevant?
2003
2003
KRP-197, 4-(2-methylimidazol-l-yl)-2,2-diphenylbutyramide, is a newly synthesized antimuscarinic drug, developed for the… (More)
Is this relevant?
1999
1999
In a study directed toward the development of new, selective agents with potential utility in the treatment of altered smooth… (More)
Is this relevant?
1998
1998
A series of N-substituted 4-amino-2,2-diphenylbutyramide derivatives was prepared as part of a search for subtype-selective… (More)
Is this relevant?